Subject Injury. If a Study subject suffers an adverse reaction, illness, or injury which, in the reasonable judgment of Institution, was directly caused by a Study Drug or Study Device or any properly performed procedures required by the Protocol, Sponsor shall reimburse for the reasonable and necessary costs of diagnosis and treatment of any Study subject injury, including hospitalization, but only to the extent such expenses are not attributable to (i) Institution's negligence or willful misconduct or (ii) the natural progression of an underlying or pre-existing condition or events, unless exacerbated by participating in the Study.
Subject Injury. If a Study subject suffers an adverse reaction, medical illness, or injury which was directly caused by a {CHOOSE: Study Drug or Study Device} and/or any properly performed procedures required by the Protocol, Sponsor shall reimburse for the reasonable and necessary expenses of diagnosis and treatment of any Study subject injury, including hospitalization, but only to the extent such adverse reaction, medical illness or injury are not directly caused by (i) Institution's negligence or willful misconduct; (ii) the natural progression of an underlying or pre-existing condition or events, unless exacerbated by participating in the Study; or (iii) Institution’s failure to adhere to and comply with the specifications of the Protocol and all reasonable written instructions furnished by Sponsor for the use and administration of any {CHOOSE: Study Drug or Study Device} used in the Study, provided that deviations from the Protocol and written instructions resulting from an imminent threat to the health or safety of a Study subject that do not cause the injury to the Study subject will not disqualify Institution from reimbursement under this provision.
Subject Injury. Sponsor shall reimburse Institution for the cost of providing necessary medical treatment to a Study subject for any injuries directly resulting from a Study subject’s participation in the Study, unless Institution’s negligence or misconduct caused the injury.
Subject Injury. A. V případě, že subjektu nastane újma přímým následkem jeho účasti v Klinickém hodnocení, jak bude společně stanoveno Zkoušejícím a Zadavatelem, bude Zdravotnické zařízení žádat o odpovídající úhradu všech souvisejících nákladů zdravotní péče pojišťovnu subjektu, plán řízené péče nebo jiný program výhod. Pokud budou náklady související s takovou újmou převyšovat rámec výdajů hrazených pojišťovnou subjektu, plánem řízené péče nebo jiným programem výhod, jak ověří Zdravotnické zařízení předtím, než bude předložen účet jakémukoli takovému plátci třetí strany, bude Zdravotnické zařízení žádat uhrazení těchto nákladů Zadavatele, Zadavatel však neposkytne žádné platby za náklady, které lze přisoudit: A. In the event that a subject is injured as a direct result of his or her participation in the Study, as determined jointly by Investigator and Sponsor, then Institution shall seek appropriate reimbursement for all related costs of care from the subject’s insurer, managed care plan, or other benefits program. If costs related to such an injury are outside the scope of covered benefits for a subject’s insurer, managed care plan, or other benefit program, as determined by Institution prior to a bill being submitted to any such third party payor, then Institution shall seek reimbursement from Sponsor for such costs; provided, however, that Sponsor shall not provide any payment for costs that are attributable to:
Subject Injury. As between the Parties, [***] shall not be liable to any Clinical Study subject for any injury, illness or side effect experienced or alleged to be experienced by such subject due to the subject’s participation in the Clinical Study, including any injury, illness or side effect caused by (a) any negligence or misconduct of [***], (b) [***], or (c) [***].
Subject Injury. The Sponsor shall reimburse actual and reasonable medical expenses incurred in treating any injury or illness to a Study Subject that is directly related to the administration of the Investigational Drug or the proper performance of any other Study procedure, each in accordance with the Protocol and the Sponsor’s written instructions to the Institution/Principal Investigator. The Sponsor is not required to provide 3.4 Újma na zdraví subjektu. Zadavatel proplatí skutečné a přiměřené léčebné výdaje, které vzniknou při léčbě újmy na zdraví nebo nemoci subjektu studie, jež bude přímo souviset s podáváním hodnoceného léčiva nebo řádným provedením jiného postupu v rámci studie, v každém případě v souladu s protokolem a písemnými pokyny zadavatele pro zdravotnické zařízení/hlavního zkoušejícího. Zadavatel není povinen compensation for (a) other injury- or illness-related costs (such as lost wages), (b) medical expenses that are paid for by a third party, (c) medical expenses that are incurred as the result of a violation of the Protocol or other misconduct or negligence, in each case by any agent or employee of the Institution (including the Study Staff), or (d) medical expenses for injury or illness unrelated to the Investigational Drug and unrelated to the proper performance of any other procedure required by the Protocol or Sponsor’s written instructions to the Institution/Principal Investigator, including, without limitation, medical expenses demonstrably associated with a pre-existing medical condition. poskytnout náhradu (a) jiných výdajů spojených s újmou na zdraví nebo nemocí (například ušlého platu), (b) léčebných výdajů, které hradí třetí strana, (c) léčebných výdajů, které vzniknou následkem porušení protokolu nebo jiného nesprávného počínání nebo nedbalosti ze strany zástupce nebo zaměstnance zdravotnického zařízení / hlavního zkoušejícího (včetně personálu studie), nebo (d) léčebných výdajů na újmu na zdraví nebo nemoc nesouvisející s hodnoceným léčivem ani s řádným provedením jiného postupu požadovaného podle protokolu nebo písemných pokynů zadavatele pro zdravotnické zařízení hlavního zkoušejícího, zejména léčebných výdajů prokazatelně souvisejících s již dříve existujícím zdravotním xxxxxx.
Subject Injury. Sponsor agrees to assume responsibility for any adverse reaction and/or injury to Study Subjects (“Subject Injury”), including the reasonable costs of treatment, that results from the Study Drug and/or a procedure required by the applicable Protocol conducted during the Study. Sponsor shall not be responsible for Subject Injury that results from:
Subject Injury. SPONSOR will provide reimbursement for the standard charges for the reasonable and necessary treatment required by the Study participant for any Research Injury (defined below) caused by or derived from the administration of the Study Drug or procedures performed under the agreed upon Protocol.
Subject Injury. Sponsor agrees that it shall pay for any illness or injury to a Study subject which the Principal Investigator determines, in his/her independent medical judgment, is caused by: 1) the investigational drug/device, 2) implementation of the Protocol, or 3) following Sponsor’s instructions.
Subject Injury. Sponsor shall reimburse the Institution for the reasonable and necessary medical expenses for the treatment of any illness or injury to a Study Subject as a direct result of the proper administration of the Study Drug or performance of any procedures in strict accordance with the Protocol. Sponsor shall not reimburse for any illness or injury to the extent such illness or injury is attributable to the: (i) Institution Indemnitees’ negligent activities, reckless misconduct, intentional misconduct or omissions; (ii) failure of Institution Indemnitees to comply with all Applicable Laws; (iii) failure of Institution Indemnitees to adhere to the terms of the Protocol or this Agreement, or (iv) the natural progression of Study Subject’s disease or underlying condition. 9.5
